BREAKTHROUGH SCIENCE. BREAKTHROUGH MEDICINE.
DEAD

Serial Number

78171952

Owner

MILLENNIUM PHARMACEUTICALS, INC.

Attorney

Michael J. Bevilacqua, Esquire

First Use Date

Aug 23, 2005

Filing Date

Oct 7, 2002

Add to watchlist:

No watchlists yet
View on USPTO

BREAKTHROUGH SCIENCE. BREAKTHROUGH MEDICINE. Trademark

Serial Number: 78171952 • Registration: 3030017

BREAKTHROUGH SCIENCE. BREAKTHROUGH MEDICINE. is a trademark filed by MILLENNIUM PHARMACEUTICALS, INC. on October 7, 2002. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

MILLENNIUM PHARMACEUTICALS, INC. (425 trademarks)

40 LANDSDOWNE STREET
CAMBRIDGE, MA 02139

Entity Type: 03

Trademark Details

Filing Date

October 7, 2002

Registration Date

December 13, 2005

First Use Anywhere

August 23, 2005

First Use in Commerce

August 23, 2005

Published for Opposition

January 6, 2004

Cancellation Date

July 20, 2012

Goods & Services

MEDICAL AND DIAGNOSTIC SERVICES, NAMELY, DIAGNOSING, PREVENTING, AND PREDICTING DISEASE, IDENTIFYING HEREDITARY RISK FACTORS, DIAGNOSTIC TESTING, PROGNOSTIC TESTING, GENE AND PROTEIN TESTING, IDENTIFYING PHYSIOLOGICAL CHARACTERISTICS, ESTABLISHING INDIVIDUAL PREVENTATIVE PROGRAMS, ESTABLISHING DISEASE TREATMENT BASED ON GENE AND PROTEIN EXPRESSION AND/OR ACTIVITY, EVALUATING CLINICAL TRIAL PROGRESS, DRUG MONITORING AND COMPUTER TRACKING OF A PATIENT'S HEALTH PROGRESS

RESEARCH SERVICES, NAMELY, RESEARCH, DEVELOPMENT, VALIDATION, TESTING, DATA ANALYSIS AND PRODUCT DEVELOPMENT SERVICES IN THE BIOMEDICAL, GENOMIC PHARMACOGENOMIC, DIAGNOSTIC, CLINICAL TRIAL DESIGN, AND BIOTECHNOLOGY FIELDS; RESEARCH CONSULTING SERVICES, NAMELY, RESEARCH, DEVELOPMENT, VALIDATION, TESTING, DATA ANALYSIS, AND PRODUCT DEVELOPMENT SERVICES FOR OTHERS IN THE BIOMEDICAL, GENOMIC, PHARMACEUTICAL, PHARMACOGENOMICS, DIAGNOSTIC, CLINICAL TRIAL DESIGN, AND BIOTECHNOLOGY FIELDS; CONSULTATION SERVICES, NAMELY, PROVIDING CONSULTATION TO OTHERS VIA GLOBAL, NATIONAL, AND LOCAL COMPUTER NETWORKS IN THE FIELDS OF LIFE SCIENCES, PHARMACOGENOMICS, DIAGNOSTICS, CLINICAL TRIAL DESIGN AND BIOTECHNOLOGY; PROVIDING ON-LINE COMPUTER DATABASES VIA GLOBAL, NATIONAL, AND LOCAL IN THE FIELDS OF LIFE SCIENCES, PHARMACOGENOMICS, DIAGNOSTICS, CLINICAL TRIAL DESIGN AND BIOTECHNOLOGY

Filing History

CANCELLED SEC. 8 (6-YR)
Jul 20, 2012 C8..
REGISTERED-PRINCIPAL REGISTER
Dec 13, 2005 R.PR
LAW OFFICE REGISTRATION REVIEW COMPLETED
Oct 26, 2005 REGV
ASSIGNED TO LIE
Oct 21, 2005 ALIE
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 17, 2005 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Oct 13, 2005 SUPC
PAPER RECEIVED
Sep 30, 2005 MAIL
USE AMENDMENT FILED
Sep 27, 2005 IUAF
SOU EXTENSION 1 GRANTED
May 10, 2005 EX1G
SOU EXTENSION 1 FILED
Apr 18, 2005 EXT1
PAPER RECEIVED
Apr 18, 2005 MAIL
NOA MAILED - SOU REQUIRED FROM APPLICANT
Oct 19, 2004 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Aug 18, 2004 ETOP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 21, 2004 TCCA
EXTENSION OF TIME TO OPPOSE RECEIVED
Jan 9, 2004 ETOF
PUBLISHED FOR OPPOSITION
Jan 6, 2004 PUBO
NOTICE OF PUBLICATION
Dec 17, 2003 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 13, 2003 CNSA
CASE FILE IN TICRS
Oct 27, 2003 CFIT
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 22, 2003 CRFA
PAPER RECEIVED
Sep 22, 2003 MAIL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 17, 2003 CRFA
NON-FINAL ACTION MAILED
Mar 17, 2003 CNRT
ASSIGNED TO EXAMINER
Mar 14, 2003 DOCK